According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are $0.35 Billion USD. , an increase over its 2023 earnings that were of -$0.95 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | $65.19 M | -106.88% |
2023 | -$0.95 Billion | -475.59% |
2022 | $0.25 B | 25.8% |
2021 | $0.20 B | 84.32% |
2020 | $0.10 B | 84.69% |
2019 | $58.94 M | -125.13% |
2018 | -$0.24 Billion | 100.62% |
2017 | -$0.12 Billion | 43.12% |
2016 | -$81.71 Million | -42.73% |
2015 | -$0.15 Billion | -24.76% |
2014 | -$0.19 Billion | -30.49% |
2013 | -$0.28 Billion | 275.65% |
2012 | -$72.63 Million | 11.56% |
2011 | -$65.1 Million | 9.38% |
2010 | -$59.52 Million | -15.21% |
2009 | -$70.2 Million |